MedTrace Logo

Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis

NCT02853175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-03-07

No results posted yet for this study

Summary

In this diagnostic study, the aim is at evaluating the diagnostic accuracy of MRI (Magnetic Resonance Imaging) to detect allergic broncho-pulmonary aspergillosis in patients with cystic fibrosis.

Conditions

  • Pulmonary Cystic Fibrosis
  • ABPA

Sponsors & Collaborators

  • University Hospital, Bordeaux

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Hôpital Haut Lévêque

    lead OTHER

Principal Investigators

  • François Laurent, MD · University Bordeaux Hospital

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853175 on ClinicalTrials.gov